tirzepatide weight loss clinic in cleveland oh Medical | Mentor, Ohio | GLP1 Medical Weight Loss Shots Near
Description
Muscle loss is a real risk of rapid weight loss with any mechanism, which is why we counsel patients on protein intake and resistance training during treatment
Patent activity remained elevated through 2022 as Lilly prepared tirzepatide for obesity treatment, culminating in the FDA approval of Zepbound in 2023 following positive SURMOUNT trial results
Thyroid antibodies For Hashimoto patients, thyroid peroxidase (TPO) and thyroglobulin (TG) antibodies indicate the degree of autoimmune activity against your thyroid
They will help you decide if this treatment is a good fit for you
It is also worth remembering that side effect frequency categories are based on clinical trial and safety reporting data
You may also want to reduce your alcohol intake while taking tirzepatide
